Axonal transport of adeno-associated viral vectors is serotype-dependent
Open Access
- 15 March 2012
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 20 (3), 348-352
- https://doi.org/10.1038/gt.2012.27
Abstract
We have previously shown that adeno-associated virus type 2 (AAV2) undergoes anterograde axonal transport in rat and non-human primate brain. We screened other AAV serotypes for axonal transport and found that AAV6 is transported almost exclusively in a retrograde direction and, in the same way as AAV2, it is also neuron-specific in rat brain. Our findings show that axonal transport of AAV is serotype dependent and this has implications for gene therapy of neurological diseases such as Huntington's disease.Keywords
This publication has 19 references indexed in Scilit:
- Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's DiseaseMolecular Therapy, 2011
- HSV trafficking and development of gene therapy vectors with applications in the nervous systemGene Therapy, 2005
- Recombinant AAV Viral Vectors Pseudotyped with Viral Capsids from Serotypes 1, 2, and 5 Display Differential Efficiency and Cell Tropism after Delivery to Different Regions of the Central Nervous SystemMolecular Therapy, 2004
- Clades of Adeno-Associated Viruses Are Widely Disseminated in Human TissuesJournal of Virology, 2004
- Rapid Uncoating of Vector Genomes Is the Key toEfficient Liver Transduction with Pseudotyped Adeno-Associated VirusVectorsJournal of Virology, 2004
- Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS ModelScience, 2003
- A New Scalable Method for the Purification of Recombinant Adenovirus VectorsHuman Gene Therapy, 2002
- Projections from the substantia nigra pars reticulata to the motor thalamus of the rat: Single axon reconstructions and immunohistochemical studyJournal of Comparative Neurology, 2001
- Pathophysiology of chorea and bradykinesia in Huntington's diseaseMovement Disorders, 1999
- Retrograde transfer of replication deficient recombinant adenovirus vector in the central nervous system for tracing studiesBrain Research, 1995